Muse Ignites Meta’s Parabolic Rally, But I’m Taking the Other Side
Here’s the news that lit the fuse, how the chart looks and what to watch from here.
Amid a Lack of Market Leadership, I’m Eyeing These 2 Stocks
I’m adding to this oil play and biopharma stock as market sees some strange and broad-but-shallow action Tuesday.
Selling SoFi After $25 Billion Stablecoin Update
The financial services firm announced a major crypto agreement with Mastercard.
Surprise Greenland Deal Has Investors Looking in the Wrong Place
Rare-earth stocks jumped on the new pact, but the best opportunity may be elsewhere. Here’s the name we bought.
As Semis Soar, I’m Upping Price Targets for AMD, Intel
INTC and AMD ran up big Monday on the sudden popularity of Meta’s Muse AI agent. Let’s chart where these two stocks could be headed.
Sticking With This Microsoft Price Target After AI Chief Sends Safety Warning
A bevy of analysts have updated their outlook on Microsoft shares today.
One of My Top Small-Cap Biotech Picks Made a Move. Here’s How I Trade It
The FDA just granted this biopharma name a key designation. Let me show you in detail how I handle a stock like this.
We’ve Got Our Eye on the ‘Sky’ as a New Position
Here’s our trading plan for the $10,000 Portfolio as we begin the week.
Just When I Thought Complacency Had Been Pushed Off the Table, It’s Back.
Finally, investors started to show some concern on Thursday, but by Friday, they were back and getting excited about the semis, which concerns me.
How to Buy the Uber Dip With a Covered-Call Strategy
Channeling Peter Lynch to invest in the rideshare giant.